The Northern Ireland Protocol (NIP) that kept NI within the EU pharma regulatory system was widely derided for failing to ...

Cost-effectiveness agency NICE has recommended NHS use of the therapy – called Kimmtrak (tebentafusp) – for the treatment of ...

Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics ...

"A prerequisite for Orexo to succeed with a sophisticated digital health product like Deprexis is a tight collaboration with ...

In its complaint, BMS alleges that HHS' Health Resources and Services Administration (HRSA), which has responsibility for ...

Alligator – which has developing mitazalimab on its own after losing Johnson & Johnson as a partner for the drug a few years ...

Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce and focus all its ...

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, ...

Today, 36 million people in the European Union (EU) and 30 million in the US with a rare disease face the harsh reality of a ...

Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...